How has been the historical performance of Brawn Biotech?

Answer:The historical performance of Brawn Biotech shows a modest financial profile with a net profit of 0.19 crore for the year ending March 2023, alongside total operating income of 0.48 crore. The company reported an operating profit of 0.24 crore, resulting in a profit before tax of 0.22 crore and a profit after tax margin of 39.58%. The earnings per share stood at 0.39, with a diluted EPS of 0.38. The company's total assets were valued at 14.37 crore, while total liabilities were slightly lower at 14.37 crore, indicating a balanced financial position with no long-term or short-term borrowings.

Breakdown:
In the fiscal year ending March 2023, Brawn Biotech generated net sales of 0.48 crore, with total operating income matching this figure. The company's total expenditure was also 0.48 crore, leading to an operating profit (PBDIT) of 0.24 crore after accounting for other income. The profit before tax was recorded at 0.22 crore, with a profit after tax of 0.19 crore. The company maintained a strong profit after tax margin of 39.58%. On the balance sheet, total assets were reported at 14.37 crore, with total liabilities also at 14.37 crore, reflecting a stable financial structure without any debt. The book value per share adjusted to 21.03, indicating a gradual decline from previous years. Overall, Brawn Biotech's financial metrics suggest a cautious but steady operational performance.